GSK3B and lung carcinoma: In line with this, sulforaphane has been found to decrease the expression of miR-616-5p, thus restraining epithelial-mesenchymal transition (EMT), and the metastasis of lung cancer through the miR-616-5p/GSK3β/β-catenin signaling pathway [103].